ArticleAmerican journal of translational research2024
Application of the Caprini risk model in preventing deep venous thrombosis formation in patients with nephrotic syndrome.
Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predicting venous thromboembolism risk after TACE in hepatocellular carcinoma: a logistic model and nursing protocol development.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the effectiveness of the Caprini model in preventing Deep venous thrombosis (DVT) in patients with nephrotic syndrome (NS), in order to provide a reference for reducing poor prognosis in patients with NS.
methodsA retrospective study was conducted on 150 cases of NS patients treated at Zibo Central Hospital from January 2021 to January 2023. Their clinical data were collected from the medical record management system of the hospital. The patients were divided into two groups: an observation group (75 patients) who received Caprini risk evaluation at admission and designed interventions based on their risk level, and a routine group (75 patients) who received conventional interventions. Clinical data, including the occurrence of DVT, renal function, inflammation, complications and satisfaction with the work of medical staff, were compared between the evaluation and routine groups.
resultsThe incidence of DVT in the observation group (6.67%) was significantly lower than that in the Routine group (17.33%) (
conclusionThe Caprini score is an effective tool for guiding predictive care in NS patients, significantly reducing the risk of DVT. Additionally, implementing risk-based interventions according to the Caprini score enhances renal function, decreases the incidence of complications, and improves patient satisfaction with nursing and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.